About Elevation Pharmaceuticals
Elevation Pharmaceuticals is a company based in San Diego (United States) founded in 2007 was acquired by Sunovion in August 2012. Elevation Pharmaceuticals has raised $77 million across 3 funding rounds from investors including TPG, Canaan and Sunovion. Elevation Pharmaceuticals offers products and services including Drug Pipeline and Clinical Trials. Elevation Pharmaceuticals operates in a competitive market with competitors including MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sunovion Pharmaceuticals Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Elevation Pharmaceuticals
Elevation Pharmaceuticals offers a comprehensive portfolio of products and services, including Drug Pipeline and Clinical Trials.
Develops treatments for oncology and rare diseases
Conducts trials for innovative health therapies
Funding Insights of Elevation Pharmaceuticals
Elevation Pharmaceuticals has successfully raised a total of $77M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Elevation Pharmaceuticals
Elevation Pharmaceuticals has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include TPG, Canaan and Sunovion.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Elevation Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Elevation Pharmaceuticals
Investment portfolio details for Elevation Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Elevation Pharmaceuticals
Detailed financials for Elevation Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elevation Pharmaceuticals Comparisons
Peer comparison for Elevation Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Elevation Pharmaceuticals
Elevation Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MediciNova, TFF Pharmaceuticals, Theravance Biopharma, Elastrin and Chance Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
|
|
| Locked | Locked | Locked |
Developer of inhalation products for chronic respiratory diseases
|
|
| Locked | Locked | Locked |
Therapeutics for inflammatory and immunological diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic targets related to arterial and lung diseases
|
|
| Locked | Locked | Locked |
Inhalation therapies for pulmonology disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutic drugs for acute inflammatory and rare diseases are developed.
|
Detailed competitors of Elevation Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elevation Pharmaceuticals
Complete news archive for Elevation Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elevation Pharmaceuticals
Elevation Pharmaceuticals was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Elevation Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Elevation Pharmaceuticals is a funded company, having raised a total of $77M across 3 funding rounds to date.
Developer of aerosol drug products for COPD patients. Its lead clinical-stage product EP-101 is an inhalation solution of a long-acting muscarinic antagonist (LAMA) bronchodilator to treat COPD.
Elevation Pharmaceuticals's top competitors include TFF Pharmaceuticals, Theravance Biopharma and MediciNova.
Elevation Pharmaceuticals offers Drug Pipeline and Clinical Trials.